Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
博士（医学）, 東京大学大学院医学系研究科
… → May 2007
External positions
Teikyo University Chiba Medical Center
Apr 2016 → …
Teikyo University Chiba Medical Center
May 2002 → Mar 2016
The University of Tokyo Hospital
Jun 1995 → Apr 2002
The University of Tokyo Hospital
Jun 1993 → May 1995
The University of Tokyo Hospital
Jun 1992 → May 1993
The University of Tokyo Hospital
Jun 1991 → May 1992
Keywords
- Hepatocellular carcinoma
Research Fields
- Gastroenterology
Fingerprint
Dive into the research topics where SHIYUNTAROU OBI is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Decoding Genomic Diversity to Guide Tumor Lesion-Specific Treatment of Multifocal Hepatocellular Carcinoma
Amemiya, K., Hirotsu, Y., Iimuro, Y., Tajiri, R., Oyama, T., Obi, S., Mochizuki, H. & Omata, M., Apr 2025, In: Cancer Medicine. 14, 7, e70814.Research output: Contribution to journal › Article › peer-review
Open Access -
Hepatic immune-related adverse event increased the overall survival of patients with malignancies treated with immune checkpoint inhibitors
Matsumoto, K., Kanda, T., Wakatsuki, J., Kim, Y. J., Yokouchi, R., Sato, N., Hasegawa, Y., Amemiya, K., Hirotsu, Y., Hirose, S., Imai, Y., Takaoka, S., Amano, H., Asakawa, Y., Nagasaka, K., Asahina, Y., Kojima, Y., Toyama, S., Mochizuki, H. & Obi, S. & 1 others, , 2025, (Accepted/In press) In: Hepatology International. 102134.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
Lau, G., Obi, S., Zhou, J., Tateishi, R., Qin, S., Zhao, H., Otsuka, M., Ogasawara, S., George, J., Chow, P. K. H., Cai, J., Shiina, S., Kato, N., Yokosuka, O., Oura, K., Yau, T., Chan, S. L., Kuang, M., Ueno, Y. & Chen, M. & 38 others, , Dec 2024, In: Hepatology International. 18, 6, p. 1661-1683 23 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
A Resected Case of Synchronous Double Cancer of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma
Nojima, H., Shimizu, H., Fujino, T., Yamazaki, K., Obi, S., Sato, T., Hirota, M., Oka, Y., Yamazaki, M., Sazuka, T., Usui, A., Mori, M., Kosugi, C., Shuto, K. & Koda, K., 1 Dec 2024, In: Japanese Journal of Cancer and Chemotherapy. 51, 13, p. 1651-1653 3 p.Research output: Contribution to journal › Article › peer-review
-
Nomograms should be noted
Obi, S. & Omata, M., Apr 2024, In: Hepatology International. 18, 2, p. 420-421 2 p.Research output: Contribution to journal › Editorial
Datasets
-
Supplementary Material for: Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Ueshima, K. (Creator), Ogasawara, S. (Creator), Ikeda, M. (Creator), Yasui, Y. (Creator), Terashima, T. (Creator), Yamashita, T. (Creator), Obi, S. (Creator), Sato, S. (Creator), Aikata, H. (Creator), Ohmura, T. (Creator), Kuroda, H. (Creator), Ohki, T. (Creator), Nagashima, K. (Creator), Ooka, Y. (Creator), Takita, M. (Creator), Kurosaki, M. (Creator), Chayama, K. (Creator), Kaneko, S. (Creator), Izumi, N. (Creator), Kato, N. (Creator), Kudo, M. (Creator) & Omata, M. (Creator), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.12705173.v1, https://karger.figshare.com/articles/Supplementary_Material_for_Hepatic_Arterial_Infusion_Chemotherapy_versus_Sorafenib_in_Patients_with_Advanced_Hepatocellular_Carcinoma/12705173/1
Dataset
-
Supplementary Material for: Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Ueshima, K. (Creator), Ogasawara, S. (Creator), Ikeda, M. (Creator), Yasui, Y. (Creator), Terashima, T. (Creator), Yamashita, T. (Creator), Obi, S. (Creator), Sato, S. (Creator), Aikata, H. (Creator), Ohmura, T. (Creator), Kuroda, H. (Creator), Ohki, T. (Creator), Nagashima, K. (Creator), Ooka, Y. (Creator), Takita, M. (Creator), Kurosaki, M. (Creator), Chayama, K. (Creator), Kaneko, S. (Creator), Izumi, N. (Creator), Kato, N. (Creator), Kudo, M. (Creator) & Omata, M. (Creator), Karger Publishers, 2020
DOI: 10.6084/m9.figshare.12705173, https://karger.figshare.com/articles/Supplementary_Material_for_Hepatic_Arterial_Infusion_Chemotherapy_versus_Sorafenib_in_Patients_with_Advanced_Hepatocellular_Carcinoma/12705173
Dataset